Skip to content
November 18, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Political Economist

Political Economist

A liberal News reporting Politics, Sports, Business, Commentaries

  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Watch Online
  • Home
  • Breaking News
  • Coronavirus: China approves clinical trials for 2 more experimental vaccines
  • Breaking News
  • International News

Coronavirus: China approves clinical trials for 2 more experimental vaccines

Admin April 14, 2020
Korea

COVID-19

China has approved clinical trials for two more experimental vaccines to combat the novel coronavirus, officials said Tuesday, as the world’s scientists race to beat the pandemic.

The vaccines use inactivated coronavirus pathogens, and the approvals pave the way for early-stage human trials, Wu Yuanbin, an official from China’s Ministry of Science and Technology told a regular press briefing.

China’s state food and drug administration on Monday approved one vaccine developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech, Wu said.

Another vaccine, being developed by the Wuhan Institute of Biological Products and the Wuhan Institute of Virology, was approved on Sunday, he added.

China now has three different clinical trials for three possible coronavirus vaccines in the works.

Beijing approved the first trial for a vaccine developed by the military-backed Academy of Military Medical Sciences and Hong Kong-listed biotech firm CanSino Bio on March 16.

That day the US drug developer Moderna said it had begun human tests for their vaccine with the US National Institutes of Health.

“Vaccination of subjects during the first phase of clinical trials and the recruitment of volunteers for the second phase of clinical trials began on April 9,” Wu said.

“It’s the world’s first novel coronavirus vaccine to initiate Phase II clinical studies.”

There are currently no approved vaccines or medication for the COVID-19 disease, which has killed more than 120,000 people worldwide and infected nearly two million.

Chinese teams were also racing to develop vaccines using other methods including using attenuated influenza virus vectors or injecting specific nucleic acid.

Several of these projects are currently undergoing animal testing and quality inspections, Wu said.

“The vaccines using the above technical methods are expected to be submitted for clinical trials in April and May,” he added.

Experts have raised hopes that a vaccine could be ready within 18 months.

AFP

  • Facebook
  • Share on X
  • LinkedIn
  • WhatsApp
  • Email
  • Copy Link
Tags: Wu Yuanbin

Post navigation

Previous Buhari commends EU for N21bn donation to Nigeria to help fight coronavirus
Next FG terminates contracts of PSPs over breach of the agreement in 4 States

Related Stories

Microsoft outage hits Outlook, Teams and Copilot worldwide Microsoft
  • International News

Microsoft outage hits Outlook, Teams and Copilot worldwide

November 13, 2026
History in New Jersey: Nigerian-Born Lawyer Shirley Emehelu Sworn In as Lieutenant Governor
  • International News

History in New Jersey: Nigerian-Born Lawyer Shirley Emehelu Sworn In as Lieutenant Governor

November 11, 2026
Top 11 ‘Firsts’ about US midterm elections: First open gay, first black governor, others
  • International News

Top 11 ‘Firsts’ about US midterm elections: First open gay, first black governor, others

November 4, 2026
logo

Political Economist is a liberal news magazine with global affiliations.

At Political Economist, we promote free enterprise and act as a catalyst for the growth of knowledge economy. We are proudly pan-Nigeria yet richly spiced with African and global news. We offer a fair and balanced news reportage presented by our team of well-heeled professional journalists. <

About us

  • 5 Olutosin Ajayi Street, By CPM Church, Ajao Estate, Lagos State, Nigeria
  • +234 805 680 1124
  • info@politicaleconomistng.com

You may have missed

Five key considerations when choosing Nigeria’s President in 2027, by Michael Owhoko
  • Commentaries

Five key considerations when choosing Nigeria’s President in 2027, by Michael Owhoko

November 18, 2026
36 state assemblies okay state police: Yilwatda commends governors, assembly members 
  • National News

36 state assemblies okay state police: Yilwatda commends governors, assembly members 

November 18, 2026
Delegates from 126 countries coming for World Public Relations Forum in Nigeria: We are ready, FG declares
  • National News

Delegates from 126 countries coming for World Public Relations Forum in Nigeria: We are ready, FG declares

November 18, 2026
INEC and the burden of trust, by Pius Mordi
  • Commentaries

INEC and the burden of trust, by Pius Mordi

November 18, 2026
  • Home
  • National News
    • Metro News
      • metro
    • Society
    • Politics
    • Crime and Justice
  • Special Reports
    • Investigation
    • Features
    • Interviews
  • Opinion
    • Business & Economy
    • Commentaries
    • Perspectives
  • Press Releases
  • International News
Copyright © All rights reserved. | DarkNews by AF themes.